Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
This book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York,
2012.
|
| Σειρά: | Current Clinical Pathology
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Introduction to Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
- Diagnostic and Prognostic Biomarkers in Melanoma: Current State of Play
- Molecular Pathogenesis of Melanoma: Established and Novel Pathways
- Staging of Melanoma
- Clinical and Histopathological Parameters in Melanoma
- Genetic/Epigenetic Biomarkers: Distinction of Melanoma from Other Melanocytic Neoplasms
- mRNA Biomarkers in Melanoma
- Epigenetic Biomarkers in Melanoma
- microRNA Biomarkers in Melanoma
- MicroRNAs as Biomarkers and Therapeutic Targets in Melanoma
- Mitochondrial DNA Biomarkers in Melanoma
- Tissue-Based Protein Biomarkers in Melanoma: Immunohistochemistry: (A) Diagnosis
- Tissue-Based Protein Biomarkers in Melanoma: Immunohistochemistry: (B) Prognostication
- Tissue-Based Protein Biomarkers in Melanoma: Mass Spectrometry-Based Strategies
- Serological Biomarkers in Melanoma
- Molecular Markers of Lymph Node Disease in Melanoma
- Melanoma Cell Propagation: Cancer Stem Cell, Clonal Evolution and Interconversion Models of Tumorigenicity
- Surgical Management of Melanoma: Concept of Field Cancerization and Molecular Evaluation of Tissue Margins
- Chemotherapy for Melanoma
- Molecular-Targeted Therapy for Melanoma
- Anti-Angiogenesis Therapy for Melanoma
- Immunological Biomarkers and Immunotherapy for Melanoma
- Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma: An Overview.
